Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
HLA-A belongs to the HLA class I heavy chain paralogues. Additionally we are shipping HLA-A Proteins (44) and HLA-A Kits (4) and many more products for this protein.
Showing 10 out of 169 products:
Human Monoclonal HLA-A Primary Antibody for FACS, ICFC - ABIN2659031
Nicodemus, Wang, Lucas, Varghese, Berek: Toll-like receptor-3 as a target to enhance bioactivity of cancer immunotherapy. in American journal of obstetrics and gynecology 2010
Show all 10 references for ABIN2659031
Human Monoclonal HLA-A Primary Antibody for FACS - ABIN2657919
Darrow, Slingluff, Seigler: The role of HLA class I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes. Evidence for shared tumor antigens. in Journal of immunology (Baltimore, Md. : 1950) 1989
Show all 9 references for ABIN2657919
Human Monoclonal HLA-A Primary Antibody for FACS - ABIN2659358
Ayyoub, Taub, Keohan, Hesdorffer, Metthez, Memeo, Mansukhani, Hibshoosh, Hesdorffer, Valmori: The frequent expression of cancer/testis antigens provides opportunities for immunotherapeutic targeting of sarcoma. in Cancer immunity 2004
Show all 9 references for ABIN2659358
Human Monoclonal HLA-A Primary Antibody for FACS, ICFC - ABIN2658757
Barbatis, Woods, Morton, Fleming, McMichael, McGee: Immunohistochemical analysis of HLA (A, B, C) antigens in liver disease using a monoclonal antibody. in Gut 1982
Show all 9 references for ABIN2658757
Human Monoclonal HLA-A Primary Antibody for FACS - ABIN2657515
De Felice, Turco, Costanzo, Corbo, Ferrone, Venuta: Inhibition by anti-HLA class I mAb of IL-2 and IL-2 receptor synthesis in lymphocytes stimulated with PHA-P. in Cellular immunology 1990
Show all 9 references for ABIN2657515
Human Monoclonal HLA-A Primary Antibody for FACS, IF - ABIN2663732
Fayen, Huang, Ferrone, Tykocinski: Negative signaling by anti-HLA class I antibodies is dependent upon two triggering events. in International immunology 1998
Show all 9 references for ABIN2663732
Human Monoclonal HLA-A Primary Antibody for FACS, IP - ABIN2662341
Geppert, Wacholtz, Patel, Lightfoot, Lipsky: Activation of human T cell clones and Jurkat cells by cross-linking class I MHC molecules. in Journal of immunology (Baltimore, Md. : 1950) 1989
Show all 9 references for ABIN2662341
Human Monoclonal HLA-A Primary Antibody for FACS - ABIN2661910
Stern, Beresford, Friedman, Stevens, Risk, Johnson: Class I-like MHC molecules expressed by baboon placental syncytiotrophoblast. in Journal of immunology (Baltimore, Md. : 1950) 1987
Show all 9 references for ABIN2661910
Mouse (Murine) Polyclonal HLA-A Primary Antibody for IHC, WB - ABIN3023100
Parham, Lomen, Lawlor, Ways, Holmes, Coppin, Salter, Wan, Ennis: Nature of polymorphism in HLA-A, -B, and -C molecules. in Proceedings of the National Academy of Sciences of the United States of America 1988
Show all 2 references for ABIN3023100
This study indicated that the frequency of the A*03 allele, the DRB1 (show RBM45 Antibodies)*03 allele, the DRB1 (show RBM45 Antibodies)*04 allele, the A*02/B*35/DRB1 (show RBM45 Antibodies)*13 haplotype, and A*02 homozygosity may play a predisposing role in patients with ALL in the Turkish population.
HLA-A*33 allele was significantly increased as compared to control population and showed geographic variation in hepatitis C virus-infected individuals of India.
A number of HLA-A alleles and haplotypes showed susceptible (A*33, A*01, A*02) and protective (A*11, A*68) association(s) in T2DM patients from south India.
Data indicate that human platelet antigen (HPA) 1-16 and human leukocyte antigen (HLA)-A and -B are highly polymorphic among ethnic Hans from Shandong, China.
Data indicate that adoptive transfer of peptide-induced cytotoxic T lymphocytes (CTL) cells from HLA-A2 transgenic mice into human tumor xenograft SCID (show PRKDC Antibodies) mice significantly inhibited tumor growth.
the carriage of HLA-A SNP rs1655900 studied is not associated with the susceptibility to CT infection based on the data from the STD (show SULT2A1 Antibodies) cohort.
Vitiligo risk associated with the MHC class I region thus derives from combined quantitative and qualitative phenomena: a SNP haplotype in a transcriptional regulator that induces gain-of-function, elevating expression of HLA-A RNA
Promiscuous Recognition of a Trypanosoma cruzi CD8 (show CD8A Antibodies)+ T Cell Epitope among HLA-A2, HLA-A24 (show CD164 Antibodies) and HLA-A1 Supertypes in Chagasic Patients.
HLA-A*31:01 was confirmed to be significantly associated with definite/probable cases of Stevens-Johnson syndrome/toxic epidermal necrolysis
The HLA-DRB1*15 allele, the A*01/B*08/DRB1*03 haplotypes, and the homozygosity of HLA-A*01 and HLA-A*02 may play a presumptive predisposing factor in Acute Myeloblastic Leukemia.
HLA-A belongs to the HLA class I heavy chain paralogues. This class I molecule is a heterodimer consisting of a heavy chain and a light chain (beta-2 microglobulin). The heavy chain is anchored in the membrane. Class I molecules play a central role in the immune system by presenting peptides derived from the endoplasmic reticulum lumen. They are expressed in nearly all cells. The heavy chain is approximately 45 kDa and its gene contains 8 exons. Exon 1 encodes the leader peptide, exons 2 and 3 encode the alpha1 and alpha2 domains, which both bind the peptide, exon 4 encodes the alpha3 domain, exon 5 encodes the transmembrane region, and exons 6 and 7 encode the cytoplasmic tail. Polymorphisms within exon 2 and exon 3 are responsible for the peptide binding specificity of each class one molecule. Typing for these polymorphisms is routinely done for bone marrow and kidney transplantation. Hundreds of HLA-A alleles have been described.
HLA class I histocompatibility antigen, A-1 alpha chain
, MHC class I antigen HLA-A heavy chain
, antigen presenting molecule
, leukocyte antigen class I-A